Interatrial Septum: Definition, Uses, and Clinical Overview

Interatrial Septum Introduction (What it is)

The Interatrial Septum is the wall of tissue that separates the heart’s right atrium from the left atrium.
It helps keep oxygen-poor and oxygen-rich blood on their correct pathways through the heart.
Clinicians commonly refer to it during echocardiograms and other heart imaging tests.
It is also an important landmark for catheter-based procedures that need access to the left atrium.

Why Interatrial Septum used (Purpose / benefits)

Because the Interatrial Septum is a key internal “divider” of the heart, it comes up in cardiovascular care for two main reasons: diagnosis and procedural access/repair.

1) Supporting normal circulation (physiologic role)
The atria are the heart’s upper chambers. The right atrium receives blood returning from the body (lower in oxygen), while the left atrium receives blood returning from the lungs (higher in oxygen). The Interatrial Septum helps prevent inappropriate mixing of these blood streams under normal conditions.

2) Identifying and characterizing structural problems (diagnostic value)
Abnormal openings or weak areas in or near the Interatrial Septum can allow blood to move (“shunt”) between atria. Detecting shunts can help clinicians evaluate:

  • Unexplained shortness of breath or reduced exercise tolerance
  • Enlargement of right-sided heart chambers
  • Pulmonary hypertension (elevated pressures in the lung circulation) in selected contexts
  • Stroke evaluation when a right-to-left passage could be relevant (interpretation is case-dependent)

3) Enabling common catheter-based procedures (procedural value)
Many modern electrophysiology and structural heart procedures require reaching the left atrium from the venous system. A controlled crossing of the Interatrial Septum (often at the fossa ovalis, a naturally thinner area) can provide a practical route for catheters without entering the arterial system.

4) Repairing defects or preventing complications in selected cases
When there is an atrial septal defect (ASD) or a patent foramen ovale (PFO), clinicians may consider closure in appropriately selected patients. The goal is typically to reduce clinically meaningful shunting or address specific risk scenarios. Whether closure is beneficial varies by clinician and case.

Clinical context (When cardiologists or cardiovascular clinicians use it)

Common scenarios where the Interatrial Septum is referenced, assessed, or intentionally crossed include:

  • Evaluating a heart murmur, right heart enlargement, or suspected atrial-level shunt
  • Assessing PFO or ASD as part of a broader workup (often using echocardiography)
  • Planning or performing atrial fibrillation ablation (left atrial access typically requires transseptal crossing)
  • Left atrial procedures such as left atrial appendage occlusion (for selected patients) or mapping of atrial arrhythmias
  • Structural heart interventions involving the mitral valve that may use a transseptal approach
  • Pre-procedural review of septal anatomy in people with congenital heart disease or prior septal repairs
  • Investigation of masses, thickening, or unusual motion of the atrial septal region on imaging (interpretation depends on imaging quality and clinical context)

Contraindications / when it’s NOT ideal

The Interatrial Septum itself is normal anatomy and is not “contraindicated.” However, procedures that cross, puncture, or close the Interatrial Septum may be less suitable in certain situations, or may require alternative strategies. Examples include:

  • Known or suspected left atrial thrombus (clot) when transseptal instrumentation could increase embolic risk
  • Active infection involving the bloodstream or heart structures, where implanted material (for closure) may be undesirable
  • Anatomy that limits safe access, such as complex congenital heart disease, unusual septal position, or prior surgical alterations (approach varies by clinician and case)
  • Prior septal closure device or patch that makes repeat crossing technically challenging or changes the safest puncture location
  • Inadequate imaging windows or inability to use necessary imaging support in settings where imaging guidance is important
  • Conditions increasing bleeding risk that may make anticoagulation or vascular access less suitable (decision-making is individualized)
  • Hemodynamic instability where delaying definitive stabilization for an elective septal procedure is not appropriate

In these situations, clinicians may consider different access routes, different imaging modalities, postponement, or surgical approaches, depending on the clinical goal.

How it works (Mechanism / physiology)

Mechanism, physiologic principle, or measurement concept

The Interatrial Septum functions as a pressure and flow barrier between the atria. Under typical adult conditions:

  • Left atrial pressure is often slightly higher than right atrial pressure, which helps keep potential flap-like regions closed.
  • If there is an opening (such as an ASD) or a flap that can separate (as in a PFO), blood may pass between atria depending on pressure differences.

Clinically, the key physiologic concept is shunting:

  • Left-to-right shunt: blood moves from the left atrium to the right atrium, which can increase flow through the right heart and lungs.
  • Right-to-left shunt: blood moves from the right atrium to the left atrium, which can allow less-oxygenated blood into systemic circulation and can be relevant in specific stroke or oxygenation evaluations.

Relevant cardiovascular anatomy and tissue involved

The Interatrial Septum is not a single uniform sheet; it includes recognizable regions:

  • Fossa ovalis: a thinner central area and frequent target for transseptal crossing
  • Surrounding muscular rim (septal tissue around the fossa ovalis)
  • Adjacent structures that matter during procedures and imaging interpretation, such as:
  • The superior and inferior vena cava (major veins entering the right atrium)
  • The pulmonary veins (entering the left atrium)
  • The mitral valve (between the left atrium and left ventricle)
  • The aorta (close anatomic neighbor that must be avoided during septal crossing)

Time course, reversibility, and interpretation

  • Anatomic findings (like a PFO or ASD) are typically stable over time, though physiologic impact can change with age, pressures, lung disease, or other conditions.
  • Some features (like the amount of shunting seen on a given test) can be variable, influenced by hydration status, breathing maneuvers, body position, and right-sided pressures.
  • If the Interatrial Septum is intentionally crossed during a catheter procedure, the puncture is typically small; whether it seals completely and how quickly can vary by technique and patient factors.

Interatrial Septum Procedure overview (How it’s applied)

The Interatrial Septum is most often assessed (not “treated”) unless there is a defect to close or a procedure requiring left atrial access. The workflow differs depending on the clinical purpose, but a general overview looks like this:

1) Evaluation / exam

  • Clinical review of symptoms, history (including prior congenital repairs or procedures), and physical exam findings
  • Noninvasive testing such as transthoracic echocardiography (TTE) to look at chamber sizes, pressures (estimated), and possible shunt clues
  • If greater detail is needed, clinicians may use transesophageal echocardiography (TEE), intracardiac echocardiography (ICE) during procedures, or cardiac CT/MRI in selected contexts

2) Preparation

  • Review of anatomy and procedural plan (for transseptal access or closure)
  • Planning imaging guidance and vascular access strategy
  • Medication planning (such as anticoagulation management) varies by clinician and case

3) Intervention / testing (two common categories)

A) Diagnostic assessment

  • Imaging focuses on septal thickness, mobility, and the presence/size of a shunt
  • “Bubble study” contrast echocardiography may be used to detect right-to-left passage, depending on the question being asked

B) Catheter-based use

  • Transseptal access: controlled crossing of the Interatrial Septum to enter the left atrium for ablation, appendage occlusion, or mitral interventions
  • Defect closure (selected cases): deployment of a closure device across a PFO/ASD or surgical repair when catheter closure is not suitable (choice varies by anatomy and clinical goals)

4) Immediate checks

  • Confirmation of catheter position (for access) or device position/stability (for closure) using imaging
  • Monitoring for rhythm changes, bleeding at access sites, and hemodynamic stability

5) Follow-up

  • Follow-up visits and imaging are commonly used to confirm expected anatomy/function after closure or to reassess symptoms and cardiac chamber response over time
  • The intensity and frequency of follow-up vary by clinician and case

Types / variations

The Interatrial Septum has important normal variations and clinically significant abnormalities.

Normal anatomy and common variants

  • Fossa ovalis prominence: the central thinner region may appear more or less distinct
  • Atrial septal aneurysm: a redundant, highly mobile portion of the septum; significance depends on associated findings and clinical context
  • Lipomatous hypertrophy of the interatrial septum: fatty thickening in the septal region that can look like a mass on imaging; interpretation depends on imaging features and symptoms

Openings or defects involving the atrial septal region

  • Patent foramen ovale (PFO): a flap-like potential opening that can allow intermittent passage between atria
  • Atrial septal defect (ASD): a true tissue defect; common subtypes include:
  • Secundum ASD (often near the fossa ovalis region)
  • Primum ASD (associated with endocardial cushion/atrioventricular septal defect spectrum)
  • Sinus venosus ASD (near venous inflow regions)
  • Coronary sinus defects (uncommon; anatomy-specific)

Variations relevant to procedures

  • Septal thickness and stiffness: may affect transseptal crossing strategy
  • Prior device/patch material: changes available puncture zones and imaging appearance
  • Congenital heart disease anatomy: may change chamber relationships and typical landmarks

Pros and cons

Pros:

  • Helps maintain efficient separation of oxygen-poor and oxygen-rich blood in normal anatomy
  • Provides a critical diagnostic window for identifying shunts that can affect heart size and lung circulation
  • Serves as a key procedural gateway for many left atrial catheter procedures
  • Can be assessed with noninvasive imaging in many patients
  • When defects are present, septal evaluation helps guide whether monitoring, catheter closure, or surgery is most appropriate
  • Offers a structured anatomic reference point for interpreting right- and left-sided filling pressures and chamber remodeling (context-dependent)

Cons:

  • Abnormal openings (PFO/ASD) can permit shunting, which may be clinically important in selected cases
  • Some septal findings are incidental and may cause anxiety without changing management
  • Imaging interpretation can be limited by image quality and patient anatomy; additional tests may be needed
  • Procedures involving transseptal crossing carry procedure-related risks (risk level varies by clinician, setting, and patient factors)
  • Closure devices or patches can complicate future transseptal access and may require specialized planning
  • Septal anatomy can be complex in congenital heart disease, making “one-size-fits-all” interpretation unreliable

Aftercare & longevity

Because the Interatrial Septum is an anatomic structure, “aftercare” depends on what was done and why.

  • After diagnostic evaluation: longevity relates to the underlying condition. Some findings require only periodic reassessment, while others prompt more focused follow-up (timing varies by clinician and case).
  • After transseptal catheter procedures (access only): immediate aftercare commonly centers on monitoring the vascular access site, heart rhythm, and short-term procedural recovery. The septal puncture is typically small, but how it heals can vary.
  • After closure of a PFO/ASD: durability depends on anatomy, device type (varies by material and manufacturer), tissue healing, and follow-up imaging findings. Medication plans and activity recommendations are individualized.

Across all scenarios, outcomes are influenced by:

  • The severity and type of septal abnormality (if present)
  • Coexisting conditions such as lung disease, pulmonary hypertension, arrhythmias, or valve disease
  • Ongoing follow-up and reassessment of symptoms and cardiac chamber size/function over time
  • The experience of the treating team and the tools used for imaging guidance (approach varies by center)

Alternatives / comparisons

How the Interatrial Septum is evaluated or approached depends on the clinical question.

Imaging comparisons (noninvasive vs more invasive imaging)

  • TTE (standard echocardiogram): widely available and noninvasive; may miss small shunts or provide limited detail in some patients.
  • TEE: provides higher-resolution views of the atrial septal region; more involved than TTE and typically requires procedural preparation.
  • ICE: often used during catheter procedures to guide transseptal crossing or device placement; usually not a standalone outpatient diagnostic test.
  • Cardiac MRI/CT: can help in selected patients for anatomy, chamber volumes, and associated structures; choice depends on the question and patient-specific factors.

Management comparisons for septal findings

  • Observation/monitoring: reasonable for some incidental or small findings when there is no clear physiologic impact; follow-up strategies vary.
  • Medication management: may address symptoms or related conditions (for example, arrhythmias or heart failure physiology) but does not “close” a structural defect.
  • Catheter-based closure: often considered for certain ASDs and selected PFO scenarios; suitability depends heavily on anatomy and clinical indication.
  • Surgical repair: may be preferred when anatomy is not suitable for device closure or when other heart surgery is needed at the same time.

Access route comparisons for left atrial procedures

  • Transseptal approach: commonly used to reach the left atrium from the venous system.
  • Retrograde arterial approach: used for some left-heart procedures but is typically not the primary route for many left atrial interventions; selection varies by procedure type and operator preference.

Interatrial Septum Common questions (FAQ)

Q: Is the Interatrial Septum a “disease”?
No. The Interatrial Septum is a normal part of heart anatomy. Clinicians focus on it because certain defects or variations (like PFO or ASD) can have clinical implications in selected situations.

Q: How do doctors check the Interatrial Septum?
It is most commonly evaluated with echocardiography, especially TTE and sometimes TEE for more detailed views. In some settings, bubble contrast studies or advanced imaging (CT/MRI) are used to answer specific questions.

Q: Can problems in the Interatrial Septum cause symptoms?
They can, depending on the type and size of the defect and the direction/amount of shunting. Some people have no symptoms, while others may develop exercise limitation, shortness of breath, or signs related to right heart strain. Symptom patterns vary widely.

Q: If a PFO or ASD is found, does it always need to be closed?
Not always. The decision depends on the clinical reason it was found, the anatomy, associated conditions, and the overall risk–benefit discussion. Management varies by clinician and case.

Q: Does evaluation of the Interatrial Septum hurt?
Standard transthoracic echocardiography is generally painless. Tests like TEE or catheter-based imaging can be more involved and may require sedation or procedural monitoring, depending on local practice.

Q: What is transseptal puncture, and why is it done?
Transseptal puncture is a controlled technique used to cross the Interatrial Septum to reach the left atrium with catheters. It is commonly used for procedures such as atrial fibrillation ablation or other left atrial interventions. Whether it is appropriate depends on anatomy and procedural goals.

Q: How long do results “last” after a septal closure?
Closure aims to provide a durable seal, but long-term results depend on anatomy, healing response, device type (varies by material and manufacturer), and follow-up findings. Some patients may have small residual leaks that are monitored over time.

Q: How safe are procedures involving the Interatrial Septum?
Many are routinely performed in specialized centers, but all invasive procedures carry risks. The types and likelihood of risks vary with the procedure, patient factors, and operator experience, so safety is best discussed in a case-specific way.

Q: Will someone need to stay in the hospital for Interatrial Septum-related procedures?
Imaging-only evaluation is typically outpatient. Catheter-based procedures or closures may involve observation or a hospital stay, depending on the intervention and the person’s overall health status; practice patterns vary.

Q: What about cost—are Interatrial Septum tests or procedures expensive?
Costs vary widely based on the test type (TTE vs TEE vs CT/MRI), the facility, insurance coverage, and whether an intervention is performed. Clinicians’ offices and hospitals typically provide estimates based on local billing practices.